Hyewon Chung

发表

Possibility of pharmacokinetic drug interaction between a DPP-4 inhibitor and a SGLT2 inhibitor

Sang-In Park, Tae-Eun Kim, SeungHwan Lee, 2020, Translational and clinical pharmacology.

Nicotinamide (niacin) supplement increases lipid metabolism and ROS‐induced energy disruption in triple‐negative breast cancer: potential for drug repositioning as an anti‐tumor agent

H. Ryu, Minsun Jung, Bohyun Kim, 2022, Molecular oncology.

Pharmacokinetics and safety of a single dose of the novel necrosis inhibitor LC28‐0126 in healthy male subjects

Hyun-Jai Cho, Sang-Heon Cho, Soon Ha Kim, 2017, British Journal of Clinical Pharmacology.

Pharmacokinetics of Ursodeoxycholic Acid in Elderly Volunteers Compared With Younger Adults in a Korean Population

S. Ji, Joo-Youn Cho, K. Yu, 2019, Journal of clinical pharmacology.

Ursodeoxycholic acid exerts hepatoprotective effects by regulating amino acid, flavonoid, and fatty acid metabolic pathways

S. Ji, Joo-Youn Cho, K. Yu, 2019, Metabolomics.

Pharmacokinetics of a Fixed-Dose Combination Product of Dapagliflozin and Linagliptin and Its Comparison with Co-Administration of Individual Tablets in Healthy Humans

Kyoung-Ah Kim, Hyewon Chung, Jin-Woo Park, 2022, Pharmaceutics.

Pharmacokinetics and Tolerability of LC28-0126, a Novel Necrosis Inhibitor, After Multiple Ascending Doses: A Phase I Randomized, Double-Blind, Placebo-Controlled Study in Healthy Male Subjects.

Eunwoo Kim, Myungwon Jin, Soon Ha Kim, 2020, Clinical therapeutics.

Pharmacokinetics of fludarabine and its association with clinical outcomes in paediatric haematopoietic stem cell transplantation patients

Ji Won Lee, K. Yu, S. Yoon, 2018, Bone Marrow Transplantation.

A randomized, double-blind, single-dose, two-arm, parallel study comparing pharmacokinetics, immunogenicity and tolerability of branded adalimumab and its biosimilar LBAL in healthy male volunteers

Joo-Youn Cho, K. Yu, I. Jang, 2017, Expert opinion on investigational drugs.

Evaluation of safety and pharmacokinetics of bismuth‐containing quadruple therapy with either vonoprazan or lansoprazole for Helicobacter pylori eradication

K. Yu, Yu Kyong Kim, Hyewon Chung, 2021, British journal of clinical pharmacology.

A thorough QT study to evaluate the QTc prolongation potential of two neuropsychiatric drugs, quetiapine and escitalopram, in healthy volunteers

Joo-Youn Cho, K. Yu, I. Jang, 2016, International clinical psychopharmacology.

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Cholic Acid (MT921) after a Subcutaneous Injection in the Submental Area to Humans

Kyoung-Ah Kim, S. Seo, Hyewon Chung, 2021, Pharmaceuticals.

Urinary bisphenol A is associated with insulin resistance and obesity in reproductive‐aged women

E. Ha, Y. Hong, K. Jeong, 2017, Clinical endocrinology.

ABCG2 Single Nucleotide Polymorphism Affects Imatinib Pharmacokinetics in Lower Alpha-1-Acid Glycoprotein Levels in Humans

Kyoung-Ah Kim, Hyewon Chung, Jin-Woo Park, 2021, Frontiers in Pharmacology.

Associations between Dietary Intake and Urinary Bisphenol A and Phthalates Levels in Korean Women of Reproductive Age

Ara Jo, N. Chang, Hyesook Kim, 2016, International journal of environmental research and public health.

Comparative pharmacokinetics of Theracurmin, a highly bioavailable curcumin, in healthy adult subjects

Ji-Young Park, Joo-Youn Cho, S. Yoon, 2021, International journal of clinical pharmacology and therapeutics.

A Significant Influence of Metronidazole on Busulfan Pharmacokinetics: A Case Report of Therapeutic Drug Monitoring.

K. Yu, H. Shin, J. Choi, 2017, Therapeutic drug monitoring.

Ocular Distribution and Pharmacokinetics of 8-Oxo-2'-Deoxyguanosine: A Novel Therapeutic Candidate of Ocular Surface Diseases.

Hyewon Chung, Dong Hyun Kim, D. Shin, 2022, Journal of Ocular Pharmacology and Therapeutics.

A pharmacokinetic comparison of two voriconazole formulations and the effect of CYP2C19 polymorphism on their pharmacokinetic profiles

Joo-Youn Cho, K. Yu, I. Jang, 2015, Drug design, development and therapy.